Yamazaki Naoya Dr. Dermatologic Oncology


Consultant - Dermatologic Oncology, experientia:

book Appointment

De doctor

Dr. Naoya cutis cancer Yamazaki est optimus artifex in in Tokyo, Iaponia.

Dr. Naoya Yamazaki est consociata cum National Center Cancri hospitalis, Japan.

hospitium

National Cancer Center, Iaponia

specializationem?

  • Dermatologic Oncology

procedendi perfecerunt

  • Dermatologic Oncology
  • Carcinoma

Research Publications &

  1. Scaena III IV Versus Nivolumab adjuvant Ipilimumab in resectum Carcinoma
  2. Plus Encorafenib Binimetinib Versus Encorafenib in Vemurafenib aut aegroti, et mutant BRAF Carcinoma (Columbus): A multicentre, Open-Label, Phase III Randomized Trial
  3. Carcinoma in aegroti et mutant-superessendam altiore BRAF Encorafenib plus recipitur vel Encorafenib Vemurafenib Binimetinib Versus (Columbus): A multicentre Aperi-Label: Randomized, Phase III Trial

  4. Carcinoma in Japan et Therapy pro targeted Immunothérapie

  5. Recurrentes, YAP1 MAML2 YAP1, et in Poroma NUTM1 Fusiones et Porocarcinoma

Auffere vult? Team est subveniat.

Volumus et recuperatis prope tuorum.

×
satus chat
Online sumus! Curabitur Cum Us!
Scan ex codice
Salve,

Welcome to CancerFax!

CancerFax est pionis suggestus dicatus singulis iunctis adversus cancer scaenae provectus cum therapiis cellulis cinematographicis sicut CAR T-CELL justo, TIL justo, et orci iudiciis per orbem terrarum.

Sciamus quid faciamus tibi.

1) Cancri foris curatio?
2) CAR T-Cell Lorem
3) Cancri vaccini
4) Online video consultationem
5) Proton Lorem